ArticleMolecular oncology2021

Genome-scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib-resistant lung cancer.

Jieun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.